Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Verifying Insulin Strategy and Initial Health Outcome Analysi Eli Lilly Ongoing N/A 4 F3Z-MC-B01 International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)
Evaluation of Asthma Management in Middle EAst North Africa Adult population ( ESMAA Study ) AstraZeneca Ongoing N/A 4 RME-XXX-20 Soliman Fakeeh Hospital (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah), Armed Forces Hospital (dhahran), King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Armed Forces Hospital (Taif), King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated Novartis Ongoing Ranibizumab 10mg/ml (Lucentis) 4 FB002A2406 King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) , Prince Sultan Military Medical City (Riyadh)
The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus King Fahad Medical City Ongoing Vitamin D Capsules 4 H-01-R-012 King Fahad Medical City (Riyadh)
Dyslipidemia International Study II: Lipid target achievement in high risk patients with Acute Coronary Syndrome (DYSIS II) MSD Ongoing N/A 4 0653A 427 Riyadh Care Hospital  (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh)
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial King Saud Medical City Ongoing Colistin 4 CCD-AFM-00 King Saud Medical City (Riyadh)
A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia Tabuk Pharmaceuticals Ongoing Tabuvan 4 T-VAHST Prince Sultan Military Medical City (Riyadh)
Glargine Insulin versus Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition King Faisal Specialist Hospital & Research Center Ongoing Lantus® 4 147 King Faisal Specialist Hospital and Research Center (Riyadh)
A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock University of Sydney Ongoing HYDROCORTISONE 4 GI-CCT3722 King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh)
Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury KAIMRC Ongoing N/A 4 RC11/056 King Abdulaziz Medical City NG (Riyadh)
View 601 - 610 From 711